4:09 PM
May 08, 2019
 |  BC Extra  |  Company News

Management tracks: Immunocore, Kyn, Engitix

Immunocore Ltd. (Abingdon, U.K.) brought on a third ex-AstraZeneca plc (LSE:AZN; NYSE:AZN) executive, hiring Mohammed Dar as head of clinical development and CMO. Dar was VP, clinical development oncology, R&D at AZ's MedImmune LLC subsidiary.

Dar's hiring follows the TCR company's appointment of David Berman as head of R&D in September 2018 and Bahija Jallal as CEO in January.

Kyn Therapeutics Inc. (Boston, Mass.) named Jeffrey Ecsedy as CSO and Jason Sager as CMO. Ecsedy was the immuno-oncology company’s SVP,...

Read the full 377 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >